GlaxoSmithKline plc (GSK.L)
LSE - LSE Delayed price. Currency in GBp
Add to watchlist
1,291.80-12.40 (-0.95%)
At close: 4:38PM GMT
| Previous close | 1,304.20 |
| Open | 1,295.20 |
| Bid | 1,291.20 x 0 |
| Ask | 1,291.60 x 0 |
| Day's range | 1,284.00 - 1,305.20 |
| 52-week range | 1,284.00 - 1,857.00 |
| Volume | 8,301,316 |
| Avg. volume | 7,525,866 |
| Market cap | 64.815B |
| Beta (5Y monthly) | 0.34 |
| PE ratio (TTM) | 10.23 |
| EPS (TTM) | 126.30 |
| Earnings date | 28 Oct 2020 |
| Forward dividend & yield | 0.76 (5.83%) |
| Ex-dividend date | 12 Nov 2020 |
| 1y target est | 1,644.50 |
- Simply Wall St.
GlaxoSmithKline plc Just Beat EPS By 44%: Here's What Analysts Think Will Happen Next
GlaxoSmithKline plc (LON:GSK) shareholders are probably feeling a little disappointed, since its shares fell 3.9% to...
- Zacks
Pharma Stock Roundup: Q3 Earnings, Resumption of AZN/JNJ Coronavirus Vaccine Study
Eli Lilly (LLY), Merck (MRK), Pfizer (PFE), Novartis (NVS) and others release Q3 results
- Motley Fool
EU Regulator Grants Label Expansion for GlaxoSmithKline's Ovarian Cancer Therapy
The European Commission has joined the Food and Drug Administration in accepting Zejula as a front-line therapy.
© 2020 Verizon Media. All rights reserved.
